Trials / Unknown
UnknownNCT02000388
Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain
Efficacy and Safety of Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management Tool for Adult Male Patients With Post-Vasectomy Pain
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Citrus Valley Medical Research, Inc. · Academic / Other
- Sex
- Male
- Age
- 25 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy, tolerability and safety of intranasal ketorolac tromethamine (SPRIX) as an option for pain management in post vasectomy patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketorolac Tromethamine | |
| OTHER | Standard of Care |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2013-12-04
- Last updated
- 2013-12-04
Source: ClinicalTrials.gov record NCT02000388. Inclusion in this directory is not an endorsement.